Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: A joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology

Clinical Endocrinology
Richard SteedsWilliam Drake

Abstract

This is a joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology on the role of echocardiography in monitoring patients receiving dopamine agonist (DA) therapy for hyperprolactinaemia. Evidence that DA pharmacotherapy causes abnormal valve morphology and dysfunction at doses used in the management of hyperprolactinaemia is extremely limited. Evidence of clinically significant valve pathology is absent, except for isolated case reports around which questions remain. Attributing change in degree of valvar regurgitation, especially in mild and moderate tricuspid regurgitation, to adverse effects of DA in hyperprolactinaemia should be avoided if there are no associated pathological changes in leaflet thickness, restriction or retraction. Note must be taken that even where morphological change in leaflet structure and function may be suspected, grading is semi-quantitative on echocardiography and may vary between different machines, ultrasound settings and operators. Decisions regarding discontinuation of medication should only be made after review of serial imaging by an echocardiographer experienced in analysing drug-induced valvulopathy or carcinoid h...Continue Reading

References

Nov 4, 2005·The New England Journal of Medicine·Antonio PineroJose Fortes
Aug 5, 2006·Clinical Endocrinology·Felipe F CasanuevaAndrea Giustina
Jan 5, 2007·The New England Journal of Medicine·René SchadeEdeltraut Garbe
Jan 5, 2007·The New England Journal of Medicine·Renzo ZanettiniGianni Pezzoli
May 6, 2008·European Journal of Endocrinology·Patrizio LancellottiAlbert Beckers
Aug 7, 2008·The Journal of Clinical Endocrinology and Metabolism·Annamaria ColaoGaetano Lombardi
Sep 23, 2008·The American Journal of Cardiology·Sanjeev BhattacharyyaJoseph Davar
Jan 9, 2009·Clinical Endocrinology·Neil HerringJohn A H Wass
Jan 15, 2010·European Journal of Endocrinology·M LafeberP M J Zelissen
Aug 19, 2010·Toxicologic Pathology·Chandikumar S Elangbam
Nov 5, 2013·The Journal of Clinical Endocrinology and Metabolism·W M DrakeUNKNOWN UK Dopamine Agonist Valvulopathy Group
Mar 1, 2016·Endocrine, Metabolic & Immune Disorders Drug Targets·Berçem Ayçiçek DoğanSerdar Güler
Nov 5, 2016·The Journal of Clinical Endocrinology and Metabolism·William M DrakeS Anyiam
Sep 10, 2017·European Heart Journal·Helmut BaumgartnerUNKNOWN ESC Scientific Document Group

❮ Previous
Next ❯

Citations

Aug 1, 2020·The Journal of Clinical Endocrinology and Metabolism·Mirela Diana Ilie, Gérald Raverot
Feb 8, 2021·The Journal of Clinical Endocrinology and Metabolism·Adrian F Daly, Albert Beckers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.